Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

0.8966 -0.0005 (-0.06%)

Delayed Quote Updated: 11:15 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

20 Stocks Moving in Monday's Pre-Market Session ↗

November 29, 2021

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results...

Via Benzinga

Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant ↗

November 29, 2021

Novavax Inc (NASDAQ: NVAX) said it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa. It said that the shot would be...

Via Benzinga

Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen ↗

November 21, 2021

Both vaccine makers still have big hurdles to jump.

Via The Motley Fool

Does This News Make Inovio Pharmaceuticals Stock a Buy? ↗

November 17, 2021

The company is closer than ever to launching its coronavirus vaccine -- but will it be good enough to make the stock worth purchasing?

Via The Motley Fool

Why Inovio Stock Is Rising Today ↗

November 10, 2021

The company received a green light to begin a U.S. phase 3 study of its COVID-19 vaccine candidate.

Via The Motley Fool

Inovio Pharmaceuticals (INO) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

INO earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Inovio Pharmaceuticals Sees A Bounce Off Support After COVID-19 Vaccine News ↗

November 09, 2021

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Tuesday after the FDA removed a hold on the company’s late-stage COVID-19 vaccine trial in the U.S....

Via Benzinga

Why Shares of Inovio Pharmaceuticals Rallied Today ↗

November 09, 2021

The FDA lifted its hold on the next step of its COVID-19 vaccine trial, although that doesn't mean much at this point.

Via The Motley Fool

RBLX Stock Alert: What Is Going on With Roblox Shares Today? ↗

November 09, 2021

Roblox (RBLX) stock is soaring higher on Tuesday following the release of the company's earnings report for the third quarter of 2021.

Via InvestorPlace

INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher ↗

November 09, 2021

Inovio Pharmaceuticals (INO) stock is pushing higher on Tuesday after providing investors with an update on its Covid-19 vaccine.

Via InvestorPlace

FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial ↗

November 09, 2021

The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Inc's (NASDAQ: INO) COVID-19 vaccine in the U.S. Inovio said it...

Via Benzinga

Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases

November 09, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the...

Via FinancialNewsMedia

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 09, 2021

Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio ↗

November 01, 2021

MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage ↗

October 18, 2021

Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral...

Via Talk Markets

Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine

October 20, 2021

Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing...

Via FinancialNewsMedia

Is This The Turning Point for Inovio? ↗

October 06, 2021

The biotech's streak of bad luck may be about to end, but risks remain.

Via The Motley Fool

New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab

October 06, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in...

Via FinancialNewsMedia

Is Vaccine Latecomer Inovio Making a Comeback? ↗

September 29, 2021

Its new plan for phase 3 trials is advancing.

Via The Motley Fool

As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024

September 23, 2021

Via FinancialNewsMedia

Looking Into Inovio Pharmaceuticals's Return On Capital Employed ↗

September 16, 2021

Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting...

Via Benzinga

Etsy And NetApp Lead The S&P 500 ↗

August 26, 2021

U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and...

Via Benzinga

Topics Economy Stocks

Why Inovio Stock Is Jumping Today ↗

August 26, 2021

The vaccine maker received some good news from Brazil.

Via The Motley Fool

Inovio Pharmaceuticals Stock Nears End Of Technical Pattern ↗

August 26, 2021

Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading...

Via Benzinga

Inovio To Start Global Late-Stage COVID-19 Vaccine Trial ↗

August 26, 2021

The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-...

Via Benzinga

Why Inovio's Stock Is Trading Higher Today ↗

August 26, 2021

Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the...

Via Benzinga

August 25, 2021

Not every stock on the popular trading app is worth owning.

Via The Motley Fool

Why Dynavax, Novavax, and Inovio Stocks Sank This Week ↗

August 20, 2021

Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.